• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双臂二分结果试验中的贝叶斯假设检验。

Bayesian hypothesis testing in two-arm trials with dichotomous outcomes.

作者信息

Zaslavsky Boris G

机构信息

FDA, CBER HFM-219, 1401 Rockville Pike, Rockville, Maryland 20852-1448, USA.

出版信息

Biometrics. 2013 Mar;69(1):157-63. doi: 10.1111/j.1541-0420.2012.01806.x. Epub 2012 Sep 24.

DOI:10.1111/j.1541-0420.2012.01806.x
PMID:23002906
Abstract

This article is motivated by an interest in comparing inferences made when using a Bayesian or frequentist statistical approach. The article addresses the study of one-sided superiority and noninferiority Bayesian tests. These tests are stated in terms of the posterior probability that the null hypothesis is true for the binomial distribution and in terms of one-sided credible limits. We restrict our considerations to conjugate beta priors with integer parameters. Under this assumption, the posterior probabilities of tested hypotheses can be transformed into the frequentist probabilities of Bernoulli trials with an adjusted number of events and population sizes. The method resembles a standard frequentist problem formulation. By using an appropriate choice of prior parameters, the posterior probabilities of the null hypothesis can be made smaller or larger than the p-values of frequentist tests.

摘要

本文的动机在于比较使用贝叶斯或频率主义统计方法时所做的推断。本文探讨单侧优效性和非劣效性贝叶斯检验的研究。这些检验是根据二项分布中零假设为真的后验概率以及单侧可信区间来表述的。我们将考虑范围限制在具有整数参数的共轭贝塔先验分布。在此假设下,被检验假设的后验概率可以转换为具有调整后事件数和总体规模的伯努利试验的频率主义概率。该方法类似于标准的频率主义问题表述。通过适当选择先验参数,零假设的后验概率可以小于或大于频率主义检验的p值。

相似文献

1
Bayesian hypothesis testing in two-arm trials with dichotomous outcomes.双臂二分结果试验中的贝叶斯假设检验。
Biometrics. 2013 Mar;69(1):157-63. doi: 10.1111/j.1541-0420.2012.01806.x. Epub 2012 Sep 24.
2
Bayesian versus frequentist hypotheses testing in clinical trials with dichotomous and countable outcomes.在具有二分法和可计数结果的临床试验中,贝叶斯方法与频率论假设检验的比较
J Biopharm Stat. 2010 Sep;20(5):985-97. doi: 10.1080/10543401003619023.
3
Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.贝叶斯统计推断增强了对当代随机对照试验的解读。
J Clin Epidemiol. 2009 Jan;62(1):13-21.e5. doi: 10.1016/j.jclinepi.2008.07.006. Epub 2008 Oct 23.
4
Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches.在频率主义和贝叶斯方法下具有多重检验的单臂临床试验中的样本量估计。
J Biopharm Stat. 2012;22(4):819-35. doi: 10.1080/10543406.2012.676585.
5
Bayesian designs and the control of frequentist characteristics: a practical solution.贝叶斯设计与频率论特征的控制:一种实用解决方案。
Biometrics. 2015 Mar;71(1):218-226. doi: 10.1111/biom.12226. Epub 2014 Sep 5.
6
Bayesian approach to noninferiority trials for proportions.比例非劣效性试验的贝叶斯方法。
J Biopharm Stat. 2011 Sep;21(5):902-19. doi: 10.1080/10543406.2011.589646.
7
Frequentist performance of Bayesian confidence intervals for comparing proportions in 2 x 2 contingency tables.2×2列联表中用于比较比例的贝叶斯置信区间的频率主义性能
Biometrics. 2005 Jun;61(2):515-23. doi: 10.1111/j.1541-0420.2005.031228.x.
8
Semiparametric bayesian testing procedure for noninferiority trials with binary endpoints.具有二元终点的非劣效性试验的半参数贝叶斯检验程序。
J Biopharm Stat. 2011 Sep;21(5):920-37. doi: 10.1080/10543406.2010.544526.
9
Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.基于二次损失函数的贝叶斯决策理论组序贯临床试验设计:频率学派评估
Clin Trials. 2007;4(1):5-14. doi: 10.1177/1740774506075764.
10
Bayesian design and analysis of composite endpoints in clinical trials with multiple dependent binary outcomes.具有多个相关二元结局的临床试验中复合终点的贝叶斯设计与分析
Pharm Stat. 2013 Jul-Aug;12(4):207-12. doi: 10.1002/pst.1572. Epub 2013 Apr 29.

引用本文的文献

1
baymedr: an R package and web application for the calculation of Bayes factors for superiority, equivalence, and non-inferiority designs.baymedr:一个用于计算优势、等效性和非劣效性设计的贝叶斯因子的 R 包和网络应用程序。
BMC Med Res Methodol. 2023 Nov 24;23(1):279. doi: 10.1186/s12874-023-02097-y.
2
Safety and Tolerability of tDCS across Different Ages, Sexes, Diagnoses, and Amperages: A Randomized Double-Blind Controlled Study.经颅直流电刺激(tDCS)在不同年龄、性别、诊断及电流强度下的安全性与耐受性:一项随机双盲对照研究。
J Clin Med. 2023 Jun 28;12(13):4346. doi: 10.3390/jcm12134346.
3
A more powerful test for three-arm non-inferiority via risk difference: Frequentist and Bayesian approaches.
一种基于风险差异的更强大的三臂非劣效性检验:频率主义和贝叶斯方法。
J Appl Stat. 2021 Nov 11;50(4):848-870. doi: 10.1080/02664763.2021.1998391. eCollection 2023.
4
Adaptive treatment allocation and selection in multi-arm clinical trials: a Bayesian perspective.多臂临床试验中的适应性治疗分配和选择:贝叶斯视角。
BMC Med Res Methodol. 2022 Feb 20;22(1):50. doi: 10.1186/s12874-022-01526-8.
5
No Impact of Stochastic Galvanic Vestibular Stimulation on Arterial Pressure and Heart Rate Variability in the Elderly Population.随机直流电前庭刺激对老年人群动脉血压和心率变异性无影响。
Front Hum Neurosci. 2021 Feb 17;15:646127. doi: 10.3389/fnhum.2021.646127. eCollection 2021.
6
New approaches for testing non-inferiority for three-arm trials with Poisson distributed outcomes.三臂试验泊松分布结局非劣效性检验的新方法。
Biostatistics. 2022 Jan 13;23(1):136-156. doi: 10.1093/biostatistics/kxaa014.
7
True and false positive rates for different criteria of evaluating statistical evidence from clinical trials.不同评估临床试验统计证据标准的真阳性率和假阳性率。
BMC Med Res Methodol. 2019 Nov 27;19(1):218. doi: 10.1186/s12874-019-0865-y.
8
Non-inferiority Testing for Risk Ratio, Odds Ratio and Number Needed to Treat in Three-arm Trial.三臂试验中风险比、比值比和需治疗人数的非劣效性检验。
Comput Stat Data Anal. 2019 Apr;132:70-83. doi: 10.1016/j.csda.2018.08.018. Epub 2018 Sep 15.
9
Cerebellum-mediated trainability of eye and head movements for dynamic gazing.小脑介导的眼球和头部运动的可训练性,用于动态注视。
PLoS One. 2019 Nov 4;14(11):e0224458. doi: 10.1371/journal.pone.0224458. eCollection 2019.
10
Bayesian hierarchical EMAX model for dose-response in early phase efficacy clinical trials.贝叶斯分层 EMAX 模型在早期疗效临床试验中的剂量反应。
Stat Med. 2019 Jul 30;38(17):3123-3138. doi: 10.1002/sim.8167. Epub 2019 May 9.